Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. (vol 367, pg 817, 2006)

被引：0
|
作者：
机构：
来源：
LANCET | 2006年 / 367卷 / 9526期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1902 / 1902
页数：1
相关论文
共 11 条
  • [1] Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
    Braitstein, P
    Brinkhof, MWG
    Dabis, F
    Schechter, M
    Boulle, A
    Miotti, P
    Wood, R
    Laurent, C
    Sprinz, E
    Seyler, C
    Bangsberg, DR
    Balestre, E
    Sterne, JAC
    May, M
    Egger, M
    [J]. LANCET, 2006, 367 (9513): : 817 - 824
  • [2] Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries - The antiretroviral therapy in low-income countries (ART-LINC) collaboration
    Tuboi, Suely H.
    Brinkhof, Martin W. G.
    Egger, Matthias
    Stone, Roslyn A.
    Braitstein, Paula
    Nash, Denis
    Sprinz, Eduardo
    Dabis, Francois
    Harrison, Lee H.
    Schechter, Mauro
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 52 - 59
  • [3] The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study (vol 390, pg 2643, 2017)
    Lear, S. A.
    Hu, W.
    Rangarajan, S.
    [J]. LANCET, 2017, 390 (10113): : 2626 - 2626
  • [4] Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean
    Tuboi, Suely H.
    Schechter, Mauro
    McGowan, Catherine C.
    Cesar, Carina
    Krolewiecki, Alejandro
    Cahn, Pedro
    Wolff, Marcelo
    Pape, Jean W.
    Padgett, Denis
    Sierra Madero, Juan
    Gotuzzo, Eduardo
    Masys, Daniel R.
    Shepherd, Bryan E.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (05) : 615 - 623
  • [5] Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study (vol 395, pg 795, 2020)
    Yusuf, S.
    Joseph, P.
    Rangarajan, S.
    [J]. LANCET, 2020, 395 (10226): : 784 - 784
  • [6] Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study (vol 396, pg 97, 2020)
    Walli-Attaei, M.
    Joseph, P.
    Rosengren, A.
    [J]. LANCET, 2020, 396 (10247): : 312 - 312
  • [7] Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study (vol 396, pg 97, 2020)
    Walli-Attaei, M.
    Joseph, P.
    Rosengren, A.
    [J]. LANCET, 2020, 396 (10257): : 1070 - 1070
  • [8] HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (vol 18, pg 17, 2017)
    Gupta, Ravindra K.
    Gregson, John
    Parkin, Neil
    Haile-Selassie, Hiwot
    Tanuri, Amilcar
    Forero, Liliana Andrade
    Kaleebu, Pontiano
    Watera, Christine
    Aghokeng, Avelin
    Mutenda, Nicholus
    Dzangare, Janet
    Hone, San
    Hang, Zaw Zaw
    Garcia, Judith
    Garcia, Zully
    Marchorro, Paola
    Beteta, Enrique
    Giron, Amalia
    Hamers, Raph
    Inzaule, Seth
    Frenkel, Lisa M.
    Chung, Michael H.
    de Oliveira, Tulio
    Pillay, Deenan
    Naidoo, Kogie
    Kharsany, Ayesha
    Kugathasan, Ruthiran
    Cutino, Teresa
    Hunt, Gillian
    Rios, Santiago Avila
    Doherty, Meg
    Jordan, Michael R.
    Bertagnolio, Silvia
    [J]. LANCET INFECTIOUS DISEASES, 2018, 18 (02): : 139 - 139
  • [9] Delayed-type hypersensitivity skin test reactivity and survival in HIV-infected patients in Uganda:: Should anergy be a criterion to start antiretroviral therapy in low-income countries?
    Jones-López, EC
    Okwera, A
    Mayanja-Kizza, H
    Ellner, JJ
    Mugerwa, RD
    Whalen, CC
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 74 (01): : 154 - 161
  • [10] HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
    Gupta, Ravindra K.
    Gregson, John
    Parkin, Neil
    Haile-Selassie, Hiwot
    Tanuri, Amilcar
    Andrade Forero, Liliana
    Kaleebu, Pontiano
    Watera, Christine
    Aghokeng, Avelin
    Mutenda, Nicholus
    Dzangare, Janet
    Hone, San
    Hang, Zaw Zaw
    Garcia, Judith
    Garcia, Zully
    Marchorro, Paola
    Beteta, Enrique
    Giron, Amalia
    Hamers, Raph
    Inzaule, Seth
    Frenkel, Lisa M.
    Chung, Michael H.
    de Oliveira, Tulio
    Pillay, Deenan
    Naidoo, Kogie
    Kharsany, Ayesha
    Kugathasan, Ruthiran
    Cutino, Teresa
    Hunt, Gillian
    Avila Rios, Santiago
    Doherty, Meg
    Jordan, Michael R.
    Bertagnolio, Silvia
    [J]. LANCET INFECTIOUS DISEASES, 2018, 18 (03): : 346 - 355
12